- Category
- Micro (2021-22)
- Udyam number
- UDYAM-TS-02-0041823

Aeternus Pharma Private Limited
About Aeternus Pharma Private Limited
Data last updated:
Aeternus Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 22 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG2021PTC155177.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹77.31 Lakh. It is led by directors including Mahendra Kuchipudi and Venkata Srinivasarao Velivela.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3 – 6 – 182/1&2 Street No.17 Urduhall Lane Himayathnagar, Hyderabad, Telangana, India – 500048.
Aeternus Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0041823).
Recognitions & Rankings of Aeternus Pharma
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address3 – 6 – 182/1&2 Street No.17 Urduhall Lane Himayathnagar, Hyderabad, Telangana, India – 500048
- IndustryChemicals, Manufacturing, Basic Chemical, Basic Chemicals Except Fertilizers And Nitrogen Compounds
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Aeternus Pharma Private Limited FY 2025 filings available
Financial Statement Summary of Aeternus Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Aeternus Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aeternus Pharma are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Aeternus Pharma Private Limited
Aeternus Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahendra Kuchipudi | Director | 22 Sep 2021 | 5 Years 0 Months | Current |
| Venkata Srinivasarao Velivela | Director | 22 Sep 2021 | 5 Years 0 Months | Current |
| Chandrahas Kolla Also directs: Hoverdock LLP, Emesco Farms Private Limited, Fervid Petrochem Private Limited and 5 more | Director | 22 Sep 2021 | 5 Years 0 Months | Current |
Charges & Borrowings of Aeternus Pharma Private Limited
Aeternus Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Aeternus Pharma Private Limited
Employment history and EPFO contributions of people linked to Aeternus Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Aeternus Pharma Private Limited
Aeternus Pharma Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Chandrahas Kolla was appointed as Director on 22 Sep 2021.
Credit Ratings, Litigation & Regulatory Alerts for Aeternus Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aeternus Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aeternus Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Aeternus Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aeternus Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aeternus Pharma Private Limited
Aeternus Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 22 September 2021 (5+ years old) and is registered under CIN U24110TG2021PTC155177.
Aeternus Pharma has 3 current directors:
- Mahendra Kuchipudi - Director
- Venkata Srinivasarao Velivela - Director
- Chandrahas Kolla - Director
The CIN (Corporate Identification Number) of Aeternus Pharma is U24110TG2021PTC155177. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aeternus Pharma was incorporated on 22 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
Chandrahas Kolla was appointed as Director on 22 Sep 2021. Mahendra Kuchipudi was appointed as Director on 22 Sep 2021. Venkata Srinivasarao Velivela was appointed as Director on 22 Sep 2021.
Yes, Aeternus Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0041823).
The registered office of Aeternus Pharma is at 3 – 6 – 1821&2 Street No.17 Urduhall Lane Himayathnagar, Hyderabad, Telangana, India – 500048.
Aeternus Pharma has an authorised share capital of ₹2 Cr and a paid-up capital of ₹77.31 Lakh.
Aeternus Pharma operates in the chemicals industry, in the manufacturing segment.
No. Aeternus Pharma is not listed on any stock exchange. It is an unlisted company.